Psoriasis Comorbidities at Hospital Calderón Guardia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorCaja Costarricense de Seguro Social
About this trial
The goal of this observational study is to characterize the epidemiologic, clinical, severity, and therapeutic features of patients with psoriasis treated in Costa Rica between 2024 and 2025. The main questions it aims to answer are:
What are the demographic and clinical characteristics and severity profiles of psoriasis patients?
What treatments are used in routine clinical practice, and how are they associated with disease severity and outcomes?
Patients with psoriasis receiving dermatologic care during the study period will be included. Data will be obtained retrospectively from electronic medical records and clinical registries without intervention or modification of treatment.
Eligibility criteria
Qualifiers
Patients evaluated in outpatient clinics during the period 2024-2025.
Patients receiving systemic therapy and/or phototherapy.
Patients aged 12 years or older, of any sex.
Availability of sufficient clinical information to assess psoriasis severity, metabolic comorbidities, atherosclerotic cardiovascular disease, and psoriatic arthritis.
Disqualifiers
Clinical records insufficient to evaluate psoriasis severity, comorbidities, or therapeutic profile.
Patients managed exclusively with topical therapies.
Duplicate or inconsistent records, preventing accurate patient classification.
Cutaneous conditions not compatible with psoriasis.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov